Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,374 across all filing types
Latest filing 2021-04-07 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2021
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/03/2021, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related activities. It includes confirmations related to securities issuance and compliance with listing rules. The content focuses on share capital changes and securities movements rather than financial performance, earnings, or management commentary. This type of document is a regulatory filing reporting share capital movements and confirmations to the stock exchange, not a full financial report or announcement of voting results. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-04-07 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2021-04-06 English
GRANT OF SHARE OPTIONS
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the grant of share options to employees under the company's Post-IPO Employee Share Option Plan (ESOP). It details the number of options granted, vesting schedules, subscription price, and the purpose of the grants. There is no financial data, earnings information, or detailed report content. The document is a regulatory announcement about share option grants, which fits the category of Share Issue/Capital Change (SHA) as it relates to changes in capital structure through share options. The document length and content confirm it is not a brief notice or a report publication announcement but a substantive announcement of a capital-related event.
2021-04-01 English
VOLUNTARY ANNOUNCEMENT-CHANGE OF THE NAME OF CONTROLLING SHAREHOLDER
Board/Management Information Classification · 95% confidence The document is a voluntary announcement regarding the change of the name of the controlling shareholder of the company. It does not contain financial data, audit information, or detailed management discussion. It is not a report or presentation but an announcement about a corporate governance-related change. The document is relatively short (2405 characters) and serves as a notification to shareholders and investors about the change in the controlling shareholder's name, without any change in control or operational impact. This fits best under the category of Board/Management Information (MANG), which includes announcements of changes in the company's board or senior management or controlling shareholders.
2021-04-01 English
Monthly Returns
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions for the month ended 31/03/2021. The content focuses on share capital changes and securities movements rather than financial performance, management commentary, or legal matters. It is a regulatory filing reporting share capital movements and related securities information to the exchange. The document is about capital structure changes and share issuance details, which aligns with the category for Share Issue/Capital Change (SHA). The document length is substantial (15,000 characters), indicating it is not a mere announcement but a detailed report of share capital movements. Therefore, the appropriate classification is SHA with high confidence.
2021-04-01 English
INSIDE INFORMATION - BUSINESS UPDATES
Regulatory Filings Classification · 95% confidence The document is an announcement from CStone Pharmaceuticals regarding the approval of a drug (AYVAKIT) by the National Medical Products Administration (NMPA) of China. It is issued pursuant to the Listing Rules and contains business updates about the drug approval, clinical significance, and company background. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is a regulatory announcement providing inside information about a significant business development, specifically a drug approval, which is material information for investors. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Investor Presentation. It is not a report publication announcement since it does not mention any report being published or attached. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories. Confidence is high given the clear nature of the announcement as a regulatory business update.
2021-03-31 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.